378701331
type: Entity
type: BFO_0000020
type: Authorship
type: Relationship
type: Continuant
type: Thing
relates: Optimizing Tildrakizumab Dosing in Psoriasis: A 52-Week Multicenter Retrospective Study Comparing 100 mg and 200 mg—IL PSO (Italian Landscape Psoriasis)

Document
type: Class

Academic Article
type: Class

Continuant
type: Class

Inglese
type: Language

Entity
type: Class

Generically Dependent Continuant
type: Class

individual
rights: termsOfUse
date: 2026-08-25T04:54:42
publisher: Optimizing Tildrakizumab Dosing in Psoriasis: A 52-Week Multicenter Retrospective Study Comparing 100 mg and 200 mg—IL PSO (Italian Landscape Psoriasis)
type: Document
label: RDF description of Optimizing Tildrakizumab Dosing in Psoriasis: A 52-Week Multicenter Retrospective Study Comparing 100 mg and 200 mg—IL PSO (Italian Landscape Psoriasis) - http://irises.unibs.it/resource/item/254350

Article
type: Class

Information Content Entity
type: Class

Optimizing Tildrakizumab Dosing in Psoriasis: A 52-Week Multicenter Retrospective Study Comparing 100 mg and 200 mg—IL PSO (Italian Landscape Psoriasis)
type: Generically Dependent Continuant
type: Document
language: Inglese
type: Continuant
type: Academic Article
type: Article
type: Thing
type: Information Content Entity
related by: 378701331
type: Entity
most specific type: Academic Article